135 related articles for article (PubMed ID: 33596450)
1. Metribuzin-induced non-adverse liver changes result in rodent-specific non-adverse thyroid effects via uridine 5'-diphospho-glucuronosyltransferase (UDPGT, UGT) modulation.
Bomann W; Tinwell H; Jenkinson P; Kluxen FM
Regul Toxicol Pharmacol; 2021 Jun; 122():104884. PubMed ID: 33596450
[TBL] [Abstract][Full Text] [Related]
2. Isoflucypram: Combining in vivo and NAMs data in a weight of evidence approach to demonstrate the human non-relevance of the mode of action leading to the subtle thyroid effects observed in the rat.
Tinwell H; Bars R
Regul Toxicol Pharmacol; 2022 Jun; 131():105154. PubMed ID: 35276315
[TBL] [Abstract][Full Text] [Related]
3. A mechanistic model of effects of dioxin on thyroid hormones in the rat.
Kohn MC; Sewall CH; Lucier GW; Portier CJ
Toxicol Appl Pharmacol; 1996 Jan; 136(1):29-48. PubMed ID: 8560478
[TBL] [Abstract][Full Text] [Related]
4. Mechanism of thiazopyr-induced effects on thyroid hormone homeostasis in male Sprague-Dawley rats.
Hotz KJ; Wilson AG; Thake DC; Roloff MV; Capen CC; Kronenberg JM; Brewster DW
Toxicol Appl Pharmacol; 1997 Jan; 142(1):133-42. PubMed ID: 9007042
[TBL] [Abstract][Full Text] [Related]
5. Mode of action of thyroid tumor formation in the male Long-Evans rat administered high doses of alachlor.
Wilson AG; Thake DC; Heydens WE; Brewster DW; Hotz KJ
Fundam Appl Toxicol; 1996 Sep; 33(1):16-23. PubMed ID: 8812207
[TBL] [Abstract][Full Text] [Related]
6. Effects of pethoxamid treatment on the disposition of thyroxine in rats.
Chandrasekaran A; Bentley K; McClanahan R; Nallani G
Toxicol Appl Pharmacol; 2024 Jun; 487():116959. PubMed ID: 38734151
[TBL] [Abstract][Full Text] [Related]
7. Mode of action and human relevance of pronamide-induced rat thyroid tumors.
Papineni S; Marty MS; Rasoulpour RJ; LeBaron MJ; Pottenger LH; Eisenbrandt DL
Regul Toxicol Pharmacol; 2015 Apr; 71(3):541-51. PubMed ID: 25707858
[TBL] [Abstract][Full Text] [Related]
8. The herbicide metolachlor induces liver cytochrome P450s 2B1/2 and 3A1/2, but not thyroxine-uridine dinucleotide phosphate glucuronosyltransferase and associated thyroid gland activity.
Dalton SR; Miller RT; Meyer SA
Int J Toxicol; 2003; 22(4):287-95. PubMed ID: 12933323
[TBL] [Abstract][Full Text] [Related]
9. Effects of TCDD on thyroid hormone homeostasis in the rat.
Kohn MC
Drug Chem Toxicol; 2000 Feb; 23(1):259-77. PubMed ID: 10711401
[TBL] [Abstract][Full Text] [Related]
10. Developmental triclosan exposure decreases maternal, fetal, and early neonatal thyroxine: a dynamic and kinetic evaluation of a putative mode-of-action.
Paul KB; Hedge JM; Bansal R; Zoeller RT; Peter R; DeVito MJ; Crofton KM
Toxicology; 2012 Oct; 300(1-2):31-45. PubMed ID: 22659317
[TBL] [Abstract][Full Text] [Related]
11. Towards a science-based testing strategy to identify maternal thyroid hormone imbalance and neurodevelopmental effects in the progeny - Part IV: the ECETOC and CLE Proposal for a Thyroid Function-Related Neurodevelopmental Toxicity Testing and Assessment Scheme (Thyroid-NDT-TAS).
Melching-Kollmuss S; Bothe K; Charlton A; Gangadharan B; Ghaffari R; Jacobi S; Marty S; Marxfeld HA; McInnes EF; Sauer UG; Sheets LP; Strupp C; Tinwell H; Wiemann C; Botham PA; van Ravenzwaay B
Crit Rev Toxicol; 2023 Jul; 53(6):339-371. PubMed ID: 37554099
[TBL] [Abstract][Full Text] [Related]
12. Male rat hepatic UDP-glucuronosyltransferase activity toward thyroxine. Activation and induction properties--relation with thyroxine plasma disappearance rate.
de Sandro V; Catinot R; Kriszt W; Cordier A; Richert L
Biochem Pharmacol; 1992 Apr; 43(7):1563-9. PubMed ID: 1567478
[TBL] [Abstract][Full Text] [Related]
13. Mechanism of trifluralin-induced thyroid tumors in rats.
Saghir SA; Charles GD; Bartels MJ; Kan LH; Dryzga MD; Brzak KA; Clark AJ
Toxicol Lett; 2008 Jul; 180(1):38-45. PubMed ID: 18582544
[TBL] [Abstract][Full Text] [Related]
14. Increased hepatobiliary clearance of unconjugated thyroxine determines DMP 904-induced alterations in thyroid hormone homeostasis in rats.
Wong H; Lehman-McKeeman LD; Grubb MF; Grossman SJ; Bhaskaran VM; Solon EG; Shen HS; Gerson RJ; Car BD; Zhao B; Gemzik B
Toxicol Sci; 2005 Apr; 84(2):232-42. PubMed ID: 15673846
[TBL] [Abstract][Full Text] [Related]
15. Increase in thyroid follicular cell tumors in nelfinavir-treated rats observed in a 2-year carcinogenicity study is consistent with a rat-specific mechanism of thyroid neoplasia.
Burns-Naas LA; Zorbas M; Jessen B; Evering W; Stevens G; Ivett JL; Ryan TE; Cook JC; Capen CC; Chen M; Furman G; Theiss JC; Webber S; Wu E; Shetty B; Gasser R; McClain RM
Hum Exp Toxicol; 2005 Dec; 24(12):643-54. PubMed ID: 16408618
[TBL] [Abstract][Full Text] [Related]
16. Evidence of chemical stimulation of hepatic metabolism by an experimental acetanilide (FOE 5043) indirectly mediating reductions in circulating thyroid hormone levels in the male rat.
Christenson WR; Becker BD; Wahle BS; Moore KD; Dass PD; Lake SG; Van Goethem DL; Stuart BP; Sangha GK; Thyssen JH
Fundam Appl Toxicol; 1996 Feb; 29(2):251-9. PubMed ID: 8742323
[TBL] [Abstract][Full Text] [Related]
17. Effects of lersivirine on canine and rodent thyroid function.
Houle CD; Finch GL; Mauthe RJ; Potter DM; Walisser JA; Gardner IB; DeWit RH
Toxicol Pathol; 2014 Jul; 42(5):897-912. PubMed ID: 24135463
[TBL] [Abstract][Full Text] [Related]
18. Towards a science-based testing strategy to identify maternal thyroid hormone imbalance and neurodevelopmental effects in the progeny-part III: how is substance-mediated thyroid hormone imbalance in pregnant/lactating rats or their progeny related to neurodevelopmental effects?
Marty MS; Sauer UG; Charlton A; Ghaffari R; Guignard D; Hallmark N; Hannas BR; Jacobi S; Marxfeld HA; Melching-Kollmuss S; Sheets LP; Urbisch D; Botham PA; van Ravenzwaay B
Crit Rev Toxicol; 2022 Aug; 52(7):546-617. PubMed ID: 36519295
[TBL] [Abstract][Full Text] [Related]
19. Alteration of thyroid homeostasis by UDP-glucuronosyltransferase inducers in rats: a dose-response study.
Liu J; Liu Y; Barter RA; Klaassen CD
J Pharmacol Exp Ther; 1995 May; 273(2):977-85. PubMed ID: 7752103
[TBL] [Abstract][Full Text] [Related]
20. Clofibrate increases hepatic triiodothyronine (T3)- and thyroxine (T4)-glucuronosyltransferase activities and lowers plasma T3 and T4 concentrations in pigs.
Luci S; Kluge H; Hirche F; Eder K
Drug Metab Dispos; 2006 Nov; 34(11):1887-92. PubMed ID: 16896063
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
